Nanotech Indonesia Global Tbk PT

JK:NANO Indonesia Medical Devices
Market Cap
$9.48 Million
Rp154.28 Billion IDR
Market Cap Rank
#32326 Global
#650 in Indonesia
Share Price
Rp36.00
Change (1 day)
-7.69%
52-Week Range
Rp22.00 - Rp81.00
All Time High
Rp176.00
About

PT Nanotech Indonesia Global Tbk, a technology company, engages in the field of research and development (R&D)-based science and technology services, materials engineering, and nanotechnology. It operates in two segments, Service and Trading. The company operates in materials, health, cosmetics, pharmacy, agribusiness and aquaculture, inspection, property and construction, and education businesse… Read more

Nanotech Indonesia Global Tbk PT (NANO) - Net Assets

Latest net assets as of June 2025: Rp169.88 Billion IDR

Based on the latest financial reports, Nanotech Indonesia Global Tbk PT (NANO) has net assets worth Rp169.88 Billion IDR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp212.00 Billion) and total liabilities (Rp42.12 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Rp169.88 Billion
% of Total Assets 80.13%
Annual Growth Rate 183.75%
5-Year Change 2704.63%
10-Year Change N/A
Growth Volatility 246.08

Nanotech Indonesia Global Tbk PT - Net Assets Trend (2019–2024)

This chart illustrates how Nanotech Indonesia Global Tbk PT's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Nanotech Indonesia Global Tbk PT (2019–2024)

The table below shows the annual net assets of Nanotech Indonesia Global Tbk PT from 2019 to 2024.

Year Net Assets Change
2024-12-31 Rp169.10 Billion +0.29%
2023-12-31 Rp168.61 Billion -0.76%
2022-12-31 Rp169.90 Billion +343.74%
2021-12-31 Rp38.29 Billion +535.06%
2020-12-31 Rp6.03 Billion +557.20%
2019-12-31 Rp917.40 Million --

Equity Component Analysis

This analysis shows how different components contribute to Nanotech Indonesia Global Tbk PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 776.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings Rp8.04 Billion 4.91%
Common Stock Rp42.85 Billion 26.15%
Other Comprehensive Income Rp525.82 Million 0.32%
Other Components Rp112.45 Billion 68.62%
Total Equity Rp163.87 Billion 100.00%

Nanotech Indonesia Global Tbk PT Competitors by Market Cap

The table below lists competitors of Nanotech Indonesia Global Tbk PT ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nanotech Indonesia Global Tbk PT's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 163,036,139,964 to 163,866,272,000, a change of 830,132,036 (0.5%).
  • Net income of 1,052,088,000 contributed positively to equity growth.
  • Share repurchases of 2,750,870 reduced equity.
  • Other comprehensive income increased equity by 594,029,231.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Rp1.05 Billion +0.64%
Share Repurchases Rp2.75 Million -0.0%
Other Comprehensive Income Rp594.03 Million +0.36%
Other Changes Rp-813.23 Million -0.5%
Total Change Rp- 0.51%

Book Value vs Market Value Analysis

This analysis compares Nanotech Indonesia Global Tbk PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.94x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 39.24x to 0.94x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 Rp0.92 Rp36.00 x
2020-12-31 Rp2.55 Rp36.00 x
2021-12-31 Rp8.12 Rp36.00 x
2022-12-31 Rp38.71 Rp36.00 x
2023-12-31 Rp38.05 Rp36.00 x
2024-12-31 Rp38.24 Rp36.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nanotech Indonesia Global Tbk PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.64%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.92%
  • • Asset Turnover: 0.55x
  • • Equity Multiplier: 1.28x
  • Recent ROE (0.64%) is below the historical average (41.92%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 171.43% 19.49% 4.74x 1.86x Rp1.48 Billion
2020 74.05% 16.32% 2.20x 2.06x Rp2.26 Billion
2021 3.57% 4.63% 0.64x 1.20x Rp-2.24 Billion
2022 1.01% 3.75% 0.24x 1.10x Rp-14.91 Billion
2023 0.83% 1.62% 0.41x 1.24x Rp-14.95 Billion
2024 0.64% 0.92% 0.55x 1.28x Rp-15.33 Billion

Industry Comparison

This section compares Nanotech Indonesia Global Tbk PT's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $9,232,023,000
  • Average return on equity (ROE) among peers: 3.34%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nanotech Indonesia Global Tbk PT (NANO) Rp169.88 Billion 171.43% 0.25x $3.72 Million
PT UBC Medical Indonesia Tbk (LABS) $9.23 Billion 3.34% 9.29x $6.71 Million